Appetite for high-growth stocks helping drive biotech IPO boom

The biotech IPO boom is expected to remain intact for the foreseeable future as investors continue to chase high-growth stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.